Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ma

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Lancet. Oncology|September 4, 2025
De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trialDaniel Ma, Katharine Price, Eric Moore, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2017
Survival in Response to Multimodal Therapy in Anaplastic Thyroid CancerNaiyarat Prasongsook, Aditi Kumar, Ashish V Chintakuntlawar, et al.
JAMA Oncology|November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain MetastasesPaul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Nature Communications|March 14, 2025
Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trialJacob J Orme, Henan Zhang, Prashanth Lingamaneni, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 8, 2025
A Proposal for HPV-Associated Oropharyngeal Carcinoma in the Ninth Edition Clinical TNM ClassificationShao Hui Huang, Jie Su, Shlomo A Koyfman, et al.
Journal of the National Cancer Institute|January 11, 2021
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC TrialNadeem Riaz, Eric Sherman, Xin Pei, et al.
International Journal of Radiation Oncology, Biology, Physics|January 18, 2025
International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Interdisciplinary Modified Delphi StudyAmy C Moreno, Erin E Watson, Laia Humbert-Vidan, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Lancet. Oncology|September 4, 2025
De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trialDaniel Ma, Katharine Price, Eric Moore, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2017
Survival in Response to Multimodal Therapy in Anaplastic Thyroid CancerNaiyarat Prasongsook, Aditi Kumar, Ashish V Chintakuntlawar, et al.
JAMA Oncology|November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain MetastasesPaul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Nature Communications|March 14, 2025
Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trialJacob J Orme, Henan Zhang, Prashanth Lingamaneni, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 8, 2025
A Proposal for HPV-Associated Oropharyngeal Carcinoma in the Ninth Edition Clinical TNM ClassificationShao Hui Huang, Jie Su, Shlomo A Koyfman, et al.
Journal of the National Cancer Institute|January 11, 2021
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC TrialNadeem Riaz, Eric Sherman, Xin Pei, et al.
International Journal of Radiation Oncology, Biology, Physics|January 18, 2025
International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Interdisciplinary Modified Delphi StudyAmy C Moreno, Erin E Watson, Laia Humbert-Vidan, et al.
Pageof 4